Shoulder Innovations (SI) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
26 Jun, 2026Opening remarks and agenda
Meeting commenced virtually with stockholders attending via webcast, chaired by the CEO and Executive Chairman.
Secretary and Inspector of Elections confirmed quorum and voting procedures, with polls opened for electronic and proxy voting.
Board members, senior management, independent auditors, and legal counsel were introduced as present.
Shareholder proposals
Two proposals were presented: election of two Class 1 directors for a three-year term and ratification of the independent auditor for 2026.
Board recommended voting in favor of both proposals.
Q&A with stakeholders
Stockholders were allowed to submit one written question each, limited to the proposals, with a 10-minute Q&A session.
No relevant questions were received during the session.
Latest events from Shoulder Innovations
- Innovative implants, AI planning, and outpatient focus drive rapid growth and market leadership.SI
Canaccord Genuity's 46th Annual Growth Conference - Registering $300M in securities and 8.1M shares for resale, targeting ASC-driven growth.SI
Registration filing - Q2 revenue up 56% YoY, guidance raised, and implant sales and innovation drive growth.SI
Q2 2026 - Innovative implants and AI-driven planning fuel rapid growth in the $2.8B shoulder arthroplasty market.SI
Investor presentation - Q1 2026 revenue surged 65% to $16.7M, with margin gains and a raised full-year outlook.SI
Q1 2026 - Annual meeting to elect directors and ratify auditor, with strong governance and risk oversight.SI
Proxy filing - Vote on director elections and auditor ratification at the June 26, 2026 annual meeting.SI
Proxy filing - Q4 revenue up 65% year-over-year; 2026 guidance targets 31–37% growth with strong margins.SI
Q4 2025 - Strong Q2 growth and innovative, efficient solutions drive momentum in the shoulder arthroplasty market.SI
Morgan Stanley 23rd Annual Global Healthcare Conference